https://www.selleckchem.com/pr....oducts/recilisib.htm
CONCLUSIONS Our results indicate that buprenorphine is modestly beneficial in reducing pain intensity in patients without OUD. Although informative, these findings should be carefully interpreted due to the small amount of data available and the variation in study designs. © The Author(s) 2020. Published by Oxford University Press on behalf of the American Academy of Pain Medicine. All rights reserved. For permissions, please e-mail [email protected] identification of new genes involved in sexual development and gonadal
Like
Comment
Share
